Integrated in vivo functional screens and multiomics analyses identify α-2,3-sialylation as essential for melanoma maintenance.

Saved in:
Bibliographic Details
Title: Integrated in vivo functional screens and multiomics analyses identify α-2,3-sialylation as essential for melanoma maintenance.
Authors: Agrawal P; Department of Pathology, NYU Grossman School of Medicine, New York, NY, USA.; Interdisciplinary Melanoma Cooperative Group, Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA.; Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, NY, USA.; Montefiore Einstein Comprehensive Cancer Center, Albert Einstein College of Medicine, Bronx, NY, USA.; Cancer Dormancy Institute, Albert Einstein College of Medicine, Bronx, NY, USA., Chen S; Department of Chemistry, New York University, New York, NY, USA., de Pablos A; Department of Pathology, NYU Grossman School of Medicine, New York, NY, USA.; Interdisciplinary Melanoma Cooperative Group, Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA.; Centro Nacional de Investigaciones Oncologicas, Madrid, Spain., Vadlamudi Y; Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, NY, USA.; Montefiore Einstein Comprehensive Cancer Center, Albert Einstein College of Medicine, Bronx, NY, USA., Vand-Rajabpour F; Department of Pathology, NYU Grossman School of Medicine, New York, NY, USA.; Interdisciplinary Melanoma Cooperative Group, Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA., Jame-Chenarboo F; Department of Chemistry, University of Alberta, Edmonton, Canada., Kar S; Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, NY, USA., Yanke AF; Department of Pathology, NYU Grossman School of Medicine, New York, NY, USA.; Interdisciplinary Melanoma Cooperative Group, Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA., Berico P; Department of Pathology, NYU Grossman School of Medicine, New York, NY, USA.; Interdisciplinary Melanoma Cooperative Group, Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA., de Vega EMS; Department of Dermatology, NYU Grossman School of Medicine, New York, NY, USA., Darvishian F; Department of Pathology, NYU Grossman School of Medicine, New York, NY, USA., Osman I; Interdisciplinary Melanoma Cooperative Group, Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA.; Department of Dermatology, NYU Grossman School of Medicine, New York, NY, USA., Lujambio A; Icahn School of Medicine at Mount Sinai, New York, NY, USA., Mahal LK; Department of Chemistry, New York University, New York, NY, USA.; Department of Chemistry, University of Alberta, Edmonton, Canada., Hernando E; Department of Pathology, NYU Grossman School of Medicine, New York, NY, USA.; Interdisciplinary Melanoma Cooperative Group, Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA.
Source: Science advances [Sci Adv] 2025 Jul 04; Vol. 11 (27), pp. eadg3481. Date of Electronic Publication: 2025 Jul 04.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
Journal Info: Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101653440 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2375-2548 (Electronic) Linking ISSN: 23752548 NLM ISO Abbreviation: Sci Adv Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2375-2548
DOI:10.1126/sciadv.adg3481